Hypoxia induced DNMT3B and SHP2 signaling promoted HCC via suppressing P53 and MYH11 protein expression

• by Hongxun Ruan, Wei Huang, Yanle Fang, Ling Xie, Xiaoning Qin

• June 15, 2026

An expression signature of 19 human endogenous retroviruses identifies immunogenic luminal breast cancers likely to respond to immunotherapy

• by Silvia Mihaela Ilie, Julie Lecuelle, François Ghiringhelli, Caroline Truntzer, Sylvain Ladoire

• June 16, 2026

Circular RNAs as molecular bridges: dual regulation of ferroptosis and immunity in cancer

• by Songbai Xu, Peiyi Liang, Tie Lin, Guangxin Zhang, Xiying Fu, Yicun Wang

• June 15, 2026

Parabilis Sets Biotech IPO Record

The clinical-stage cancer biotech raised $670 million in an upsized Nasdaq debut, with a further $75 million expected from a concurrent Regeneron private placement

• June 15, 2026

• 2 min